Sw. Quan et al., RIBOSYLATIVE INACTIVATION OF RIFAMPIN BY MYCOBACTERIUM-SMEGMATIS IS APRINCIPAL CONTRIBUTOR TO ITS LOW SUSCEPTIBILITY TO THIS ANTIBIOTIC, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2456-2460
Mycobacterium smegmatis inactivates rifampin by ribosylating this anti
biotic. The gene responsible for this ability was cloned and was shown
to confer low-level resistance to this antibiotic (MIC increase, abou
t 12-fold) in related organisms. A 600-bp subclone responsible for rib
osylating activity and resistance carried an open reading frame of 429
bp. Targeted disruption of the gene in M. smegmatis resulted in mutan
ts with much increased susceptibility to rifampin (MICs of 1.5 instead
of 20 mu g/ml) as well as the loss of antibiotic-inactivating ability
. Also, disruption of this gene led to a much lower frequency of occur
rence of spontaneous high-level rifampin-resistant mutants.